- Home
- JBLU vs VCEL Comparison
JBLU vs VCEL Comparison
Compare JBLU & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- VCEL
- Stock Information
- Founded
- JBLU 1998
- VCEL 1989
- Country
- JBLU United States
- VCEL United States
- Employees
- JBLU N/A
- VCEL N/A
- Industry
- JBLU Air Freight/Delivery Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JBLU Consumer Discretionary
- VCEL Health Care
- Exchange
- JBLU Nasdaq
- VCEL Nasdaq
- Market Cap
- JBLU 2.0B
- VCEL 2.1B
- IPO Year
- JBLU N/A
- VCEL 1997
- Fundamental
- Price
- JBLU $4.91
- VCEL $31.42
- Analyst Decision
- JBLU Sell
- VCEL Strong Buy
- Analyst Count
- JBLU 10
- VCEL 6
- Target Price
- JBLU $4.97
- VCEL $61.50
- AVG Volume (30 Days)
- JBLU 17.9M
- VCEL 677.8K
- Earning Date
- JBLU 10-28-2025
- VCEL 11-06-2025
- Dividend Yield
- JBLU N/A
- VCEL N/A
- EPS Growth
- JBLU N/A
- VCEL 2045.40
- EPS
- JBLU N/A
- VCEL 0.13
- Revenue
- JBLU $9,138,000,000.00
- VCEL $249,119,000.00
- Revenue This Year
- JBLU N/A
- VCEL $18.35
- Revenue Next Year
- JBLU $7.48
- VCEL $22.47
- P/E Ratio
- JBLU N/A
- VCEL $234.59
- Revenue Growth
- JBLU N/A
- VCEL 16.13
- 52 Week Low
- JBLU $3.34
- VCEL $30.26
- 52 Week High
- JBLU $8.31
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- JBLU 45.64
- VCEL 36.46
- Support Level
- JBLU $5.06
- VCEL $30.26
- Resistance Level
- JBLU $5.31
- VCEL $33.92
- Average True Range (ATR)
- JBLU 0.26
- VCEL 1.52
- MACD
- JBLU -0.06
- VCEL -0.22
- Stochastic Oscillator
- JBLU 6.82
- VCEL 17.55
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.